We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

82 hedge funds and large institutions have $78.6M invested in Genesis Healthcare, Inc. in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 24

0% more funds holding

Funds holding: 8282 (0)

0% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 14

44% less capital invested

Capital invested by funds: $139M → $78.6M (-$60.6M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
82
Holders Change
Holders Change %
0%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
14
Increased
28
Reduced
24
Closed
14
Calls
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$614K
Name Holding Trade Value Shares
Change
Change in
Stake
HighTower Advisors
1
HighTower Advisors
Illinois
$15.1M
CPA
2
Columbia Pacific Advisors
Washington
$9.93M +$284K +59,402 +2%
Invesco
3
Invesco
Georgia
$7.67M +$119K +24,888 +1%
CC
4
Cannell Capital
Wyoming
$5.92M +$769K +160,520 +10%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$3.47M +$477K +99,700 +11%
BFA
6
BlackRock Fund Advisors
California
$3.38M +$133K +27,755 +3%
DM
7
Deerfield Management
New York
$3.34M -$2.75M -574,668 -37%
BIT
8
BlackRock Institutional Trust
California
$3.01M +$94.9K +19,821 +2%
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.66M +$230K +48,088 +7%
MCM
10
Mazama Capital Management
Oregon
$1.96M +$633K +132,230 +31%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$1.86M -$75K -15,668 -3%
RFC
12
Russell Frank Company
Washington
$1.71M -$27.9K -5,829 -1%
FM
13
Forward Management
California
$1.69M +$256K +53,477 +12%
Northern Trust
14
Northern Trust
Illinois
$1.42M -$18K -3,762 -0.9%
State Street
15
State Street
Massachusetts
$1.37M +$44.2K +9,239 +2%
TC
16
TFS Capital
Pennsylvania
$1.17M +$742K +154,936 +86%
Goldman Sachs
17
Goldman Sachs
New York
$1.16M +$539K +112,575 +51%
Renaissance Technologies
18
Renaissance Technologies
New York
$998K +$47.3K +9,878 +4%
PAM
19
Panagora Asset Management
Massachusetts
$785K +$918K +191,795 +554%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$662K +$731K +152,610 +401%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$582K +$7.23K +1,509 +0.9%
EIM
22
Essex Investment Management
Massachusetts
$558K -$20.7K -4,314 -3%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$504K +$24.2K +5,062 +4%
GC
24
Globeflex Capital
California
$481K -$801K -167,253 -55%
BIM
25
BlackRock Investment Management
Delaware
$476K +$1.14K +237 +0.2%

GEN Hedge Fund Activity: Q4 2015 in Review

82 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q4 2015, worth a combined $78.6M — down 44% from $139M a quarter earlier.

Fund positioning in GEN was balanced in Q4 2015: 14 funds opened new positions, 14 closed out, 28 added to existing stakes and 24 trimmed.

The largest buyer was Panagora Asset Management, adding an estimated $918K. The largest seller was Deerfield Management, cutting an estimated $2.75M.

  • 82 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $78.6M of Genesis Healthcare, Inc. stock for Q4 2015, down 44% quarter-over-quarter.
  • 14 funds opened new Genesis Healthcare, Inc. positions in Q4 2015 and 14 closed out, a net change of 0 holders.
  • The largest Genesis Healthcare, Inc. buyer in Q4 2015 was Panagora Asset Management, an estimated $918K added.
  • The largest Genesis Healthcare, Inc. seller in Q4 2015 was Deerfield Management, an estimated $2.75M sold.

Based on aggregated 13F filings for Q4 2015.